Inhibition of CD4 translation mediated by human immunodeficiency virus type 1 envelope protein in a cell-free system.
The human immunodeficiency virus type 1 (HIV-1) employs a number of complex strategies to interfere with the synthesis, stability, and subcellular localization of its specific cellular receptor CD4. To define better the mechanisms of inhibition of CD4 expression, we used a rabbit reticulocyte lysate in vitro system, in which cDNAs derived from HIV-1-infected cells were used to generate mRNA for the Tat, Vpu, and gp160 envelope proteins that were translated together with CD4-encoding mRNA. In the presence of microsomal membranes, we observed that cotranslation of Env mRNA resulted in a dose-dependent inhibition of CD4 translation. This effect was enhanced further when an mRNA-encoding Vpu in addition to Env mRNA was utilized. However, the activity of Vpu was mostly post-translational, since translation of Vpu alone, but not Env, was able to destabilize CD4 molecules presynthesized into microsomes. The Env-mediated inhibitory effect was specifically targeted at CD4 and did not affect the synthesis or stability of the CD8 molecule. Interestingly, mutated CD4 species, with a 20-fold lower affinity for HIV-1 Env than wild-type, were less sensitive to cotranslational inhibition. Our report identifies the envelope as the HIV-1 protein responsible for down-regulation of CD4 translation. We further propose a mechanism whereby direct interactions between gp160 and nascent CD4 molecules can cause interference with and premature termination of CD4 protein elongation.
Bour
S
S
McGill University AIDS Centre, Lady Davis Institute-Jewish General Hospital, Montr-eal, Qu-ebec H3T 1E2, Canada. sb32i@nih.gov
Geleziunas
R
R
Wainberg
M A
MA
D000818:Animals; D001665:Binding Sites; D015704:CD4 Antigens / Q000235:genetics*; D002474:Cell-Free System; D005814:Genes, Viral; D019302:HIV Envelope Protein gp160 / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D054298:Human Immunodeficiency Virus Proteins; D006801:Humans; D009154:Mutation; D014176:Protein Biosynthesis / Q000502:physiology*; D012333:RNA, Messenger / Q000235:genetics; D011817:Rabbits; D054334:Viral Regulatory and Accessory Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D000086082:Viroporin Proteins
D015704:CD4 Antigens; D019302:HIV Envelope Protein gp160; D054298:Human Immunodeficiency Virus Proteins; D012333:RNA, Messenger; D054334:Viral Regulatory and Accessory Proteins; C514859:vpu protein, Human immunodeficiency virus 1; D000086082:Viroporin Proteins